Rapid Decline of Viral RNA in Hepatitis C Patients Treated With VX-950: A Phase Ib, Placebo-Controlled, Randomized Study
To access this article, please choose from the options below
Supported by Vertex Pharmaceuticals Incorporated.
PII: S0016-5085(06)01539-3
doi:10.1053/j.gastro.2006.07.013
© 2006 American Gastroenterological Association (AGA) Institute. Published by Elsevier Inc. All rights reserved.

